The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February 14

Thursday, January 24, 2013

Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February 1408:00 EST Thursday, January 24, 2013 WILMINGTON, Del. (Business Wire) -- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter/year-end 2012 financial results conference call for 8:30 a.m. ET on Thursday, February 14, 2013. The schedules for the press release and conference call are as follows:       -- Q4 & YE 2012 Press Release: February 14, 2013 at 7:00 a.m. ET -- Q4 & YE 2012 Conference Call: February 14, 2013 at 8:30 a.m. ET -- Domestic Dial In Number: 877-407-8037 -- International Dial In Number: 201-689-8037 -- Conference ID # 407848   If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 407848. The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. About Incyte Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com. Incyte CorporationPamela M. MurphyVice President, Investor Relations & Corporate Communications302-498-6944